<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01890642</url>
  </required_header>
  <id_info>
    <org_study_id>443133-1</org_study_id>
    <nct_id>NCT01890642</nct_id>
  </id_info>
  <brief_title>The Use of Jet Injection Lidocaine for Blood Draws in Young Children</brief_title>
  <official_title>Use Of The Needle Free Jet-Injection System With Buffered Lidocaine (J-Tip) For The Treatment Of Pain During Venipuncture For Blood Draws In Young Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical College of Wisconsin</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study looks at the use of Jet Injection Lidocaine (J tip) for pain during blood draws in
      children ages 6 and younger. The investigators will use video observation of patients to
      asses their pain during lab draws using either 1) Jet Injected lidocaine ( J tip) 2) Pain
      Ease spray 3) Pain Ease spray plus the J tip noise.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      No change since last report.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pain Score on FLACC Scale From Device Deployment to Venipuncture</measure>
    <time_frame>3 min</time_frame>
    <description>Pain score assessed by video reviewer at J-tip, J-tip noise or researcher approach (1 minute) and at venipuncture (3 minutes). The score at J-tip noise/researcher approach was subtracted from the score at venipuncture to give a number indicating the change in pain scores.
The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>At venipuncture (3 minutes)</time_frame>
    <description>Pain score as assessed by video reviewers. The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fist Attempt Success</measure>
    <time_frame>up to 3 minutes</time_frame>
    <description>Proportion of patients where blood draw was successful on first attempt</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pain Score From Baseline</measure>
    <time_frame>3 min</time_frame>
    <description>Pain score assessed by video reviewer before intervention (0 minute) and at venipuncture (3 minutes). The score at baseline was subtracted from the score at venipuncture to give a number indicating the change in pain scores.
The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at J-tip Deployment</measure>
    <time_frame>1 minute</time_frame>
    <description>Pain when J-tip deployed assessed by video reviewers using pain scale. The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">205</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>J tip Noise</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>This group will have a J tip deployed without medication to create the noise that the device makes. They will also receive Pain Ease spray if &gt; age 1 yr or sucrose if &lt; 1 yr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pain Ease</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group will receive Pain Ease Spray only if &gt; 1 yr or sucrose only if child &lt; 1 yr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>J tip</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive 1% buffered lidocaine via Jet Injection. They will receive placebo cooling spray (normal saline spray) to maintain blinding if &gt; 1 yr and will receive sucrose is &lt; 1 yr</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>J tip</intervention_name>
    <description>This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine</description>
    <arm_group_label>J tip Noise</arm_group_label>
    <arm_group_label>J tip</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pain Ease Spray</intervention_name>
    <description>Cold Spray used to anesthetize the skin</description>
    <arm_group_label>J tip Noise</arm_group_label>
    <arm_group_label>Pain Ease</arm_group_label>
    <other_name>Cooling Spray</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1% buffered lidocaine</intervention_name>
    <description>Lidocaine placed using Jet Injection</description>
    <arm_group_label>J tip</arm_group_label>
    <other_name>Lidocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo cooling spray (normal saline spray)</intervention_name>
    <description>Normal Saline Sprayed as placebo for Pain Ease spray</description>
    <arm_group_label>J tip</arm_group_label>
    <other_name>Normal Saline Spray</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sucrose</intervention_name>
    <description>Oral Sucrose used for children &lt; 1 year</description>
    <arm_group_label>J tip Noise</arm_group_label>
    <arm_group_label>Pain Ease</arm_group_label>
    <arm_group_label>J tip</arm_group_label>
    <other_name>Sweetease</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 6 months-6 years seen in the Children's Hospital of Wisconsin outpatient
             laboratory that have an order for venipuncture for a blood draw

        Exclusion Criteria:

          -  Previous adverse reaction to lidocaine or Pain Ease spray

          -  Pre-existing skin lesion at site of blood draw

          -  Needle stick for IV insertion or lab draw that has already occurred at current
             hospital visit

          -  Patients who are physically unable to move their arms or legs

          -  Patients who are unable to cry

          -  Patients with connective tissue disorders that predispose to easy bruising

          -  Patients with bleeding disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maren Lunoe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of Wisconsin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amy Drendel, DO, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of Wisconsin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2013</study_first_submitted>
  <study_first_submitted_qc>July 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2013</study_first_posted>
  <results_first_submitted>May 22, 2015</results_first_submitted>
  <results_first_submitted_qc>September 2, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 6, 2015</results_first_posted>
  <last_update_submitted>September 2, 2015</last_update_submitted>
  <last_update_submitted_qc>September 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Children</keyword>
  <keyword>Venipuncture</keyword>
  <keyword>J tip</keyword>
  <keyword>Lidocaine</keyword>
  <keyword>video observation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Salicylates</mesh_term>
    <mesh_term>Camphor</mesh_term>
    <mesh_term>Menthol</mesh_term>
    <mesh_term>Methyl salicylate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>J Tip Noise</title>
          <description>This group will have a J tip deployed without medication to create the noise that the device makes. They will also receive Pain Ease spray
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
        </group>
        <group group_id="P2">
          <title>Pain Ease</title>
          <description>This group will receive Pain Ease Spray
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
        </group>
        <group group_id="P3">
          <title>J Tip</title>
          <description>This group will receive 1% buffered lidocaine via Jet Injection. They will receive placebo cooling spray (normal saline spray) to maintain blinding
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
1% buffered lidocaine: Lidocaine placed using Jet Injection
placebo cooling spray (normal saline spray): Normal Saline Sprayed as placebo for Pain Ease spray</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="53"/>
                <participants group_id="P3" count="96"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="53"/>
                <participants group_id="P3" count="96"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>J Tip Noise</title>
          <description>This group will have a J tip deployed without medication to create the noise that the device makes. They will also receive Pain Ease spray
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
        </group>
        <group group_id="B2">
          <title>Pain Ease</title>
          <description>This group will receive Pain Ease Spray
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
        </group>
        <group group_id="B3">
          <title>J Tip</title>
          <description>This group will receive 1% buffered lidocaine via Jet Injection. They will receive placebo cooling spray (normal saline spray) to maintain blinding
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
1% buffered lidocaine: Lidocaine placed using Jet Injection
placebo cooling spray (normal saline spray): Normal Saline Sprayed as placebo for Pain Ease spray</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="56"/>
            <count group_id="B2" value="53"/>
            <count group_id="B3" value="96"/>
            <count group_id="B4" value="205"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="96"/>
                    <measurement group_id="B4" value="205"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.4" spread="1.6"/>
                    <measurement group_id="B2" value="2.9" spread="1.7"/>
                    <measurement group_id="B3" value="3.3" spread="1.9"/>
                    <measurement group_id="B4" value="3.2" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="54"/>
                    <measurement group_id="B4" value="122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="45"/>
                    <measurement group_id="B4" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="96"/>
                    <measurement group_id="B4" value="205"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Venipuncture</title>
          <description>Reported Previous Venipuncture Experience. 3 parents stated they did not know if their child had previous venipuncture, accounting for the difference between the number enrolled in the study and the number on which this variable was collected.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="96"/>
                    <measurement group_id="B4" value="202"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score</title>
        <description>Pain score as assessed by video reviewers. The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
        <time_frame>At venipuncture (3 minutes)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>J Tip Noise</title>
            <description>This group will have a J tip deployed without medication to create the noise that the device makes. They will also receive Pain Ease spray
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O2">
            <title>Pain Ease</title>
            <description>This group will receive Pain Ease Spray
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O3">
            <title>J Tip</title>
            <description>This group will receive 1% buffered lidocaine via Jet Injection. They will receive placebo cooling spray (normal saline spray) to maintain blinding
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
1% buffered lidocaine: Lidocaine placed using Jet Injection
placebo cooling spray (normal saline spray): Normal Saline Sprayed as placebo for Pain Ease spray</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score</title>
          <description>Pain score as assessed by video reviewers. The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.75" lower_limit="2.75" upper_limit="9"/>
                    <measurement group_id="O2" value="8" lower_limit="3.5" upper_limit="10"/>
                    <measurement group_id="O3" value="5.25" lower_limit="1.5" upper_limit="8.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fist Attempt Success</title>
        <description>Proportion of patients where blood draw was successful on first attempt</description>
        <time_frame>up to 3 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>J Tip Noise</title>
            <description>This group will have a J tip deployed without medication to create the noise that the device makes. They will also receive Pain Ease spray
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O2">
            <title>Pain Ease</title>
            <description>This group will receive Pain Ease Spray
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O3">
            <title>J Tip</title>
            <description>This group will receive 1% buffered lidocaine via Jet Injection. They will receive placebo cooling spray (normal saline spray) to maintain blinding
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
1% buffered lidocaine: Lidocaine placed using Jet Injection
placebo cooling spray (normal saline spray): Normal Saline Sprayed as placebo for Pain Ease spray</description>
          </group>
        </group_list>
        <measure>
          <title>Fist Attempt Success</title>
          <description>Proportion of patients where blood draw was successful on first attempt</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.80</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Pain Score From Baseline</title>
        <description>Pain score assessed by video reviewer before intervention (0 minute) and at venipuncture (3 minutes). The score at baseline was subtracted from the score at venipuncture to give a number indicating the change in pain scores.
The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
        <time_frame>3 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>J Tip Noise</title>
            <description>This group will have a J tip deployed without medication to create the noise that the device makes. They will also receive Pain Ease spray
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O2">
            <title>Pain Ease</title>
            <description>This group will receive Pain Ease Spray
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O3">
            <title>J Tip</title>
            <description>This group will receive 1% buffered lidocaine via Jet Injection. They will receive placebo cooling spray (normal saline spray) to maintain blinding
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
1% buffered lidocaine: Lidocaine placed using Jet Injection
placebo cooling spray (normal saline spray): Normal Saline Sprayed as placebo for Pain Ease spray</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pain Score From Baseline</title>
          <description>Pain score assessed by video reviewer before intervention (0 minute) and at venipuncture (3 minutes). The score at baseline was subtracted from the score at venipuncture to give a number indicating the change in pain scores.
The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.32" spread="0.48"/>
                    <measurement group_id="O2" value="3.7" spread="0.49"/>
                    <measurement group_id="O3" value="1.58" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.004</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Pain Score on FLACC Scale From Device Deployment to Venipuncture</title>
        <description>Pain score assessed by video reviewer at J-tip, J-tip noise or researcher approach (1 minute) and at venipuncture (3 minutes). The score at J-tip noise/researcher approach was subtracted from the score at venipuncture to give a number indicating the change in pain scores.
The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
        <time_frame>3 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>J Tip Noise</title>
            <description>This group will have a J tip deployed without medication to create the noise that the device makes. They will also receive Pain Ease spray
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O2">
            <title>Pain Ease</title>
            <description>This group will receive Pain Ease Spray
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O3">
            <title>J Tip</title>
            <description>This group will receive 1% buffered lidocaine via Jet Injection. They will receive placebo cooling spray (normal saline spray) to maintain blinding
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
1% buffered lidocaine: Lidocaine placed using Jet Injection
placebo cooling spray (normal saline spray): Normal Saline Sprayed as placebo for Pain Ease spray</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pain Score on FLACC Scale From Device Deployment to Venipuncture</title>
          <description>Pain score assessed by video reviewer at J-tip, J-tip noise or researcher approach (1 minute) and at venipuncture (3 minutes). The score at J-tip noise/researcher approach was subtracted from the score at venipuncture to give a number indicating the change in pain scores.
The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.71" spread="0.42"/>
                    <measurement group_id="O2" value="2.82" spread="0.45"/>
                    <measurement group_id="O3" value="0.23" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0001</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at J-tip Deployment</title>
        <description>Pain when J-tip deployed assessed by video reviewers using pain scale. The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
        <time_frame>1 minute</time_frame>
        <group_list>
          <group group_id="O1">
            <title>J Tip Noise</title>
            <description>This group will have a J tip deployed without medication to create the noise that the device makes. They will also receive Pain Ease spray
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O2">
            <title>Pain Ease</title>
            <description>This group will receive Pain Ease Spray
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
          </group>
          <group group_id="O3">
            <title>J Tip</title>
            <description>This group will receive 1% buffered lidocaine via Jet Injection. They will receive placebo cooling spray (normal saline spray) to maintain blinding
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
1% buffered lidocaine: Lidocaine placed using Jet Injection
placebo cooling spray (normal saline spray): Normal Saline Sprayed as placebo for Pain Ease spray</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at J-tip Deployment</title>
          <description>Pain when J-tip deployed assessed by video reviewers using pain scale. The FLACC (Face, legs, activity, cry and consolability) Scale, ranging from 0 (no pain) to 10 (worst pain), was used to assess pain.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="56"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.25" lower_limit="0.5" upper_limit="7.25"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.5" upper_limit="6.5"/>
                    <measurement group_id="O3" value="4.0" lower_limit="0.5" upper_limit="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.37</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Patients were assessed for serious events immediately following venipuncture and then the next day via phone follow up.</time_frame>
      <desc>All patients were assessed for serious adverse events in the lab. Attempts were made to contact the families of all patients the next day for follow up. The research team was unable to contact some families for follow up, therefore the number of patients assessed for Other Adverse Events is smaller than those assessed for Serious Adverse Events.</desc>
      <group_list>
        <group group_id="E1">
          <title>J Tip Noise</title>
          <description>This group will have a J tip deployed without medication to create the noise that the device makes. They will also receive Pain Ease spray
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
        </group>
        <group group_id="E2">
          <title>Pain Ease</title>
          <description>This group will receive Pain Ease Spray
Pain Ease Spray: Cold Spray used to anesthetize the skin</description>
        </group>
        <group group_id="E3">
          <title>J Tip</title>
          <description>This group will receive 1% buffered lidocaine via Jet Injection. They will receive placebo cooling spray (normal saline spray) to maintain blinding
J tip: This is a Jet Injection system which for our study will be loaded with 1% buffered lidocaine
1% buffered lidocaine: Lidocaine placed using Jet Injection
placebo cooling spray (normal saline spray): Normal Saline Sprayed as placebo for Pain Ease spray</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="96"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>Bruise</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="46"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="83"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title vocab="Other">Other/Not Specified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="46"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="83"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bruise present at 24 hours</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="46"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="83"/>
              </event>
              <event>
                <sub_title vocab="Redness">Redness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="46"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="83"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Maren Lunoe</name_or_title>
      <organization>Medical College of Wisconsin</organization>
      <phone>414-266-2625</phone>
      <email>mlunoe@mcw.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

